Eye Infections
VIDEO: ARMOR study reveals trends in antibiotic resistance for ocular diseases
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Penny A. Asbell, MD, FACS, MBA, of the University of Memphis, discusses results from the ARMOR surveillance study.
Provectus, University of Miami agreement will advance photodynamic antimicrobial therapy
Provectus Biopharmaceuticals announced an exclusive worldwide license agreement with the University of Miami for the university’s photodynamic antimicrobial therapy to treat bacterial, fungal and parasitic eye infections.
Top stories in 2023: FDA approvals, warning letters, recalls
FDA warnings about potentially contaminated over-the-counter eye drops topped the news on Healio Optometry this year.
Q&A: FDA warning a reminder that consumers should use doctor-recommended eye drops
The recent FDA warning about 26 potentially contaminated eye drop products, including some marketed under CVS Health, Leader, Rugby, Rite Aid, Target Up&Up and Velocity Pharma, may have caused some confusion among consumers.
VIDEO: Physicians should consider methicillin resistance when treating eye infections
CHICAGO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, MBA, discusses the ARMOR study, the largest surveillance study of eye infections in the U.S.
Consider resistance before empirically treating eye infections
BOSTON — Results from the ARMOR study indicate that about 70% of Staphylococcus organisms in the eye are resistant to commonly used antibiotics.